Pharmaceutical intermediates are actually some chemical raw materials or chemical products used in the process of pharmaceutical synthesis.This kind of chemical product, do not need the production license of medicine, can produce in ordinary chemical plant, want to reach a few level, can be used in the synthesis of medicine.
Analysis of pharmaceutical intermediates industry in China.
In China, there are more than 2,000 kinds of raw materials and intermediates, and the demand is over 2.5 million tons.After more than 30 years of development, the chemical raw materials and intermediates needed for pharmaceutical production in China are basically matched, and only a few need to be imported.Moreover, due to the abundant resources and low raw material prices, many intermediates have been exported.
Throughout the industry, there are six major characteristics of pharmaceutical intermediates in China:
The first is that the production enterprises are mostly private enterprises, operating flexibly, and the investment is small, which is basically between millions and 20 million yuan.The second is the geographical distribution of the production enterprises, mainly distributed in zhejiang taizhou and jiangsu jintan as the center of the region;Third, with the increasing attention of the state to environmental protection, the pressure of production enterprises to build environmental protection treatment facilities increases.Fourth, the product is updated quickly.After three to five years, the profit margin of a product is greatly reduced, which compels the enterprise to constantly develop new products or continuously improve the production process, so as to maintain a higher production profit.5 it is because the manufacture of pharmaceutical intermediates profit higher than that of chemical products, the production process is basically the same, so there are more and more small chemical companies join the production of pharmaceutical intermediates, results in a disorderly competition increasingly fierce in the industry;Six is compared with the active pharmaceutical ingredients, intermediates production profit margins is low, and active pharmaceutical ingredients and pharmaceutical intermediates production process is similar, therefore, some enterprises have not only production intermediates, also used their own advantages, to start producing active pharmaceutical ingredients.
Pharmaceutical intermediates product line in our country, based bulk drug intermediates, upstream in the product due to the application field is wide, occupy the advantage position of the chain, thus obtained the rapid development, also in the market.
However, the export of pharmaceutical intermediates in China has come under pressure from other countries, especially India.India's rapid rise in the pharmaceutical industry is now associated with competition and symbiosis with our country.It has been proved that the impact from India is not negligible in the European Union, North America, Middle East, southeast Asia, etc., which is the main export area of pharmaceutical intermediates in China.
Champ consulting released "2014-2017 China pharmaceutical intermediates market analysis depth research report shows that China's pharmaceutical intermediates industry itself also exist such as the low value-added products, the lack of independent intellectual property products, export channels and information support is insufficient, inadequate information resource utilization and so on aspects of the" short board ", plus water and electricity coal transport and chemical raw materials prices, the rising cost of environmental protection, and part of the medical commodity export tax rebates and other external cause, competitive threats to its international market advantage.